Met Life Investment Management, LLC Nkarta, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 31,197 shares of NKTX stock, worth $73,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,197

Previous 31,197 -0.0%

Holding current value

$73,000

Previous $184,000 23.37%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.27 - $10.82 $80,251 - $164,766	15,228 Added 95.36%	31,197 $184,000
Q1 2024 May 14, 2024	BUY	$5.59 - $15.71 $89,266 - $250,872	15,969 New	15,969 $172,000
Q2 2023 Apr 29, 2024	BUY	$2.19 - $5.17 $35,782 - $84,472	16,339 New	16,339 $35,000
Q2 2023 Aug 10, 2023	BUY	$2.19 - $5.17 $20,671 - $48,799	9,439 Added 136.8%	16,339 $35,000
Q1 2023 May 09, 2024	BUY	$3.37 - $6.3 $23,253 - $43,470	6,900 New	6,900 $24.5 Million
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $34,417 - $64,341	-10,213 Reduced 59.68%	6,900 $24,000
Q4 2022 Jun 14, 2023	BUY	$5.14 - $14.35 $52,494 - $146,556	10,213 Added 148.01%	17,113 $102,000
Q3 2022 Jun 14, 2023	BUY	$12.27 - $18.39 $125,313 - $187,817	10,213 Added 148.01%	17,113 $225,000
Q2 2022 May 10, 2024	BUY	$7.77 - $19.44 $132,968 - $332,676	17,113 New	17,113 $210,000
Q2 2022 Jun 20, 2023	BUY	$7.77 - $19.44 $79,355 - $198,540	10,213 Added 148.01%	17,113 $210,000
Q2 2022 Mar 22, 2023	BUY	$7.77 - $19.44 $76,689 - $191,872	9,870 Added 136.27%	17,113 $210,000
Q2 2022 Aug 11, 2022	BUY	$7.77 - $19.44 $132,968 - $332,676	17,113 New	17,113 $211,000
Q4 2021 Feb 15, 2022	SELL	$12.79 - $26.88 $92,637 - $194,691	-7,243 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$26.67 - $38.76 $9,147 - $13,294	343 Added 4.97%	7,243 $201,000
Q2 2021 Jun 21, 2023	BUY	$23.94 - $36.68 $8,211 - $12,581	343 Added 4.97%	7,243 $229,000
Q1 2021 May 17, 2024	SELL	$31.33 - $59.61 $273,385 - $520,156	-8,726 Reduced 54.64%	7,243 $238,000
Q1 2021 Jun 26, 2023	BUY	$31.33 - $59.61 $10,746 - $20,446	343 Added 4.97%	7,243 $238 Million
Q4 2020 Jun 22, 2023	BUY	$27.03 - $75.62 $9,271 - $25,937	343 Added 4.97%	7,243 $445,000
Q3 2020 May 24, 2024	SELL	$23.52 - $47.9 $205,235 - $417,975	-8,726 Reduced 54.64%	7,243 $218 Million
Q3 2020 Jun 26, 2023	BUY	$23.52 - $47.9 $8,067 - $16,429	343 Added 4.97%	7,243 $217,000
Q3 2020 Mar 22, 2023	SELL	$23.52 - $47.9 $232,142 - $472,773	-9,870 Reduced 57.68%	7,243 $217,000
Q3 2020 Nov 13, 2020	BUY	$23.52 - $47.9 $170,355 - $346,939	7,243 New	7,243 $218,000

Others Institutions Holding NKTX

# of Institutions

127

Shares Held

66.6M

Call Options Held

173K

Put Options Held

20K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $114M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Nkarta, Inc. Transaction History